Clinical Trials Directory

Trials / Completed

CompletedNCT00223002

Chlorhexidine Versus Povidone-Iodine for Prevention of Epidural Needle Contamination in the Parturient

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
University of Saskatchewan · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Infection after epidural catheter placement is fortunately rare. When it does happen, the affected person can become seriously ill. This study examines which skin disinfectant, chlorhexidine or povidone-iodine, decreases the number of bacteria that can be grown from the skin washed with each disinfectant prior to placing an epidural catheter for pain control in labour.

Detailed description

The use of chlorhexidine for skin asepsis for the placement of intravascular catheters is known to decrease the incidence of central line colonization and blood stream infection when compared to the use of povidone-iodine. While the development of an infectious complication following spinal or epidural analgesia, such as epidural abscess or meningitis, is fortunately rare, when it does happen, there can be devastating consequences for the affected individual. The low frequency of infection makes a trial with an endpoint of clinical infection not feasible, however a reduction in skin and needle contamination following attempts at asepsis should reduce the risk of infectious complication. Ongoing work by the authors is examining the skin culture rates following randomized standardized skin disinfection. The purpose of this randomized trial is to compare needle culture rates to further assess effectiveness of skin disinfection following a standardized skin preparation with either povidone-iodine or chlorhexidine in pregnant women requesting lumbar epidural pain relief in labour.

Conditions

Interventions

TypeNameDescription
DRUGChlorhexidinesample collected at time of procedure and then analysed for bacterial contamination

Timeline

Start date
2004-11-01
Primary completion
2007-01-01
Completion
2008-01-01
First posted
2005-09-22
Last updated
2009-02-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00223002. Inclusion in this directory is not an endorsement.